About: Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT) Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 September 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2018 (uk) im September 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2018 (ast) scientific article published on 20 September 2018 (en)
publication date	wds:Q57155059-5C04D2B9-56C7-40ED-8910-0A6514E30632
publication date	2018-09-20 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57155059-64245F2E-2BD1-400D-A18F-864FA8681369
language of work or name	English
cites work	wds:Q57155059-006EEA3E-F7BF-4A0A-8B3E-E23FB53F28DB wds:Q57155059-0393B05D-CE72-43A8-8050-1F54C3068F11 wds:Q57155059-06677657-C2A0-4956-8BA2-9636C4482778 wds:Q57155059-153CC2E8-675B-4222-AE62-5129F652CA9A wds:Q57155059-187C5BC0-349B-4222-880B-F29D267DADDE wds:Q57155059-28CA0482-6265-46BE-8B83-C5AD422BAA64 wds:Q57155059-2C592674-D073-41BA-9FB8-DC9F1C4B24E1 wds:Q57155059-2D8F0E19-8D09-4866-963C-6096DE952212 wds:Q57155059-32278F35-BF30-4174-82A2-D0C693504C7F wds:Q57155059-3696D0F8-94BB-400D-8F7A-BA97E2007117 wds:Q57155059-3C6188BE-D31B-4AC7-A75C-01222B7D177B wds:Q57155059-3D781EC0-2D32-438E-88F6-F944139B7288 wds:Q57155059-3F2E5BA8-1083-4822-8E79-DE9A0BAA9BC5 wds:Q57155059-427485B3-BBB3-4308-8252-274330FD6412 wds:Q57155059-43DF6244-E778-41FE-AA4B-B48011D46D02 wds:Q57155059-49804289-AFC7-4B18-96AB-08D78B287B4D wds:Q57155059-5037A742-214A-452C-8349-C01FCD872642 wds:Q57155059-5488006B-1814-4F7C-A9DD-F7F2CBD8DD32 wds:Q57155059-599BFE01-9341-4413-9C23-5E3B81821295 wds:Q57155059-5A20B225-0698-4C37-A45C-AC86DCC91956 wds:Q57155059-6BE246E7-33C3-4360-984A-CE16E744ACB4 wds:Q57155059-6F04ED02-5166-42E1-8A3A-41E198B2BEAA wds:Q57155059-86A09EB3-4839-4D99-AAE6-79D73962AD0C wds:Q57155059-D571C013-307B-4059-976F-7449ECFB0118 wds:Q57155059-D8DAEC46-C5B6-414E-90C6-FB13FB8221E5 wds:Q57155059-E33195F9-3084-47DD-8A69-E2705F9ADA39
cites work	Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Reduced lung-cancer mortality with low-dose computed tomographic screening A new method of classifying prognostic comorbidity in longitudinal studies: development and validation Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study Differential prognostic impact of comorbidity Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer Comorbidity and Survival in Lung Cancer Patients Prognostic importance of comorbidity in a hospital-based cancer registry Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Towards a close computed tomography monitoring approach for screen detected subsolid pulmonary nodules? Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection. The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks Analysis It's never too late: Smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Prediction of Early Death in Patients with Early-Stage NSCLC-Can We Select Patients without a Potential Benefit of SBRT as a Curative Treatment Approach? Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis. Age-not Charlson Co-morbidity Index-predicts for mortality after stereotactic ablative radiotherapy for medically inoperable stage I non-small cell lung cancer. Comorbidity in Lung Cancer: A Prospective Cohort Study of Self-Reported versus Register-Based Comorbidity.
author name string	wds:Q57155059-114D2D9B-E2FC-4422-9D15-5672DD8C100D wds:Q57155059-7C3A27B1-B7B4-43D7-8B84-883A7ECC9912 wds:Q57155059-A09D0C38-75CD-4F69-B7A8-9ED4B81F5D1A wds:Q57155059-A36E3B36-BDB1-453A-9444-BB883D1C7ED9 wds:Q57155059-FE4F1ADC-FD3C-4DDF-A8E4-429E56F2D3FD
author name string	Cliff G Robinson Jeffrey D Bradley Todd A DeWees Sana Rehman John Nikitas
rdfs:label	Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (nl) Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT) (en)
skos:prefLabel	Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (nl) Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT) (en)
name	Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (nl) Defining Optimal Comorbidity Measures for Patients with Early Stage Non-small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT) (en)
author	wds:Q57155059-FCF360CD-B113-4392-B939-4DA097099033
author	Michael Roach
title	wds:Q57155059-990075DC-D7C8-4FB4-B914-9FB9A610F568
title	Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy (en)
page(s)	wds:Q57155059-342D1D62-E876-45C7-B5F6-053A0DC43BA6
page(s)	e83-e89
instance of	wds:Q57155059-166FB97B-4A13-4DD6-A4A2-193022FCB3B8
instance of	scholarly article
main subject	wds:Q57155059-228733D3-A146-4AE4-8A75-01930BDCFF65 wds:Q57155059-6FA7B32F-7B16-46C9-8366-F84383D55D8C
main subject	comorbidity non-small-cell lung carcinoma
PubMed ID	wds:Q57155059-F3B46DFF-05F6-4104-AD17-D12ADCD6722C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30244094
PubMed ID	30244094
published in	wds:Q57155059-40669E80-63AB-4E0B-B9B1-A280B0001BB3
published in	Practical radiation oncology
issue	wds:Q57155059-E9D6A36D-391B-4E02-8916-86AC6E4599C0
volume	wds:Q57155059-EFDD6383-D6B6-42E4-9FA5-9736FDF11E2F
issue	1
volume	9
DOI	wds:Q57155059-D5831494-9915-4371-A5E7-5E71A26D78B3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software